<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font27 { font-size : 27; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">rubella </span>
   <span class="font27">age </span>
   <span class="font27">.(.â€".) </span>
   <span class="font23">â€" </span>
   <span class="font22">group </span>
   <span class="font21">MMR </span>
   <span class="font19">years </span>
   <span class="font19">antibodies </span>
   <span class="font19">vaccine </span>
   <span class="font18">study </span>
   <span class="font18">aged </span>
   <span class="font17">percentage </span>
   <span class="font17">Health </span>
   <span class="font17">IgG </span>
   <span class="font17">children </span>
   <span class="font16">levels </span>
   <span class="font16">antibody </span>
   <span class="font16">higher </span>
   <span class="font16">period </span>
   <span class="font15">[]. </span>
   <span class="font15">coverage </span>
   <span class="font15">immunity </span>
   <span class="font15">{border-style </span>
   <span class="font15">Vojvodina </span>
   <span class="font15">seropositive </span>
   <span class="font15">individuals </span>
   <span class="font15">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">anti-rubella </span>
   <span class="font14">level </span>
   <span class="font14">results </span>
   <span class="font14">statistically </span>
   <span class="font14">Rubella </span>
   <span class="font14">number </span>
   <span class="font14">Vojvodina, </span>
   <span class="font14">dose </span>
   <span class="font14">groups </span>
   <span class="font14">immunization </span>
   <span class="font14">lower </span>
   <span class="font14">participants </span>
   <span class="font14">Sciences </span>
   <span class="font14">population </span>
   <span class="font14">years, </span>
   <span class="font13">Public </span>
   <span class="font13">samples </span>
   <span class="font13">used </span>
   <span class="font13">vaccination </span>
   <span class="font13">Total </span>
   <span class="font13">compared </span>
   <span class="font13">disease </span>
   <span class="font13">infection </span>
   <span class="font13">obtained </span>
   <span class="font13">Institute </span>
   <span class="font13">cases </span>
   <span class="font13">incidence </span>
   <span class="font13">virus </span>
   <span class="font12">;():â€". </span>
   <span class="font12">observed </span>
   <span class="font12">significant </span>
   <span class="font12">significantly </span>
   <span class="font12">(.%) </span>
   <span class="font12">Biology </span>
   <span class="font12">European </span>
   <span class="font12">Medicine </span>
   <span class="font12">born </span>
   <span class="font12">gender </span>
   <span class="font12">received </span>
   <span class="font12">reported </span>
   <span class="font12">susceptible </span>
   <span class="font12">&amp;lt;. </span>
   <span class="font12">Immunization </span>
   <span class="font12">analysis </span>
   <span class="font12">difference </span>
   <span class="font12">doses </span>
   <span class="font12">highest </span>
   <span class="font12">px; </span>
   <span class="font12">seropositives </span>
   <span class="font12">serum </span>
   <span class="font12">study, </span>
   <span class="font12">test </span>
   <span class="font12">women </span>
   <span class="font12">{font-family </span>
   <span class="font12">Available </span>
   <span class="font12">Life </span>
   <span class="font12">Novi </span>
   <span class="font12">Serbia </span>
   <span class="font12">Serbia. </span>
   <span class="font12">acquired </span>
   <span class="font12">different </span>
   <span class="font12">effect </span>
   <span class="font12">females </span>
   <span class="font12">font-size </span>
   <span class="font12">individual </span>
   <span class="font12">possible </span>
   <span class="font12">second </span>
   <span class="font12">subjects </span>
   <span class="font12">vaccine. </span>
   <span class="font12">â‰¥ </span>
   <span class="font12">â€", </span>
   <span class="font11">Antibodies </span>
   <span class="font11">CRS </span>
   <span class="font11">Centre </span>
   <span class="font11">Pathogens </span>
   <span class="font11">Region </span>
   <span class="font11">Sad, </span>
   <span class="font11">Serbian. </span>
   <span class="font11">Viral </span>
   <span class="font11">Vojvodina. </span>
   <span class="font11">[,]. </span>
   <span class="font11">according </span>
   <span class="font11">certain </span>
   <span class="font11">conducted </span>
   <span class="font11">determine </span>
   <span class="font11">double; </span>
   <span class="font11">elimination </span>
   <span class="font11">equivocal </span>
   <span class="font11">from: </span>
   <span class="font11">included </span>
   <span class="font11">introduction </span>
   <span class="font11">males </span>
   <span class="font11">measles </span>
   <span class="font11">older </span>
   <span class="font11">patients </span>
   <span class="font11">protective </span>
   <span class="font11">rate </span>
   <span class="font11">seronegative </span>
   <span class="font11">study. </span>
   <span class="font11">year </span>
   <span class="font11">years. </span>
   <span class="font11">Fig </span>
   <span class="font11">However, </span>
   <span class="font11">Immune </span>
   <span class="font11">Infect </span>
   <span class="font11">Republic </span>
   <span class="font11">World </span>
   <span class="font11">[accessed </span>
   <span class="font11">additional </span>
   <span class="font11">belongs </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">collected </span>
   <span class="font11">contact </span>
   <span class="font11">countries </span>
   <span class="font11">data </span>
   <span class="font11">epidemics </span>
   <span class="font11">especially </span>
   <span class="font11">explained </span>
   <span class="font11">generative </span>
   <span class="font11">high </span>
   <span class="font11">infection. </span>
   <span class="font11">lowest </span>
   <span class="font11">maternal </span>
   <span class="font11">outbreak </span>
   <span class="font11">people </span>
   <span class="font11">performed </span>
   <span class="font11">period, </span>
   <span class="font11">pre-vaccination </span>
   <span class="font11">previously </span>
   <span class="font11">registered </span>
   <span class="font11">risk </span>
   <span class="font11">solid; </span>
   <span class="font11">using </span>
   <span class="font11">vaccine, </span>
   <span class="font11">values </span>
   <span class="font11">virus. </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">&amp;lt;.). </span>
   <span class="font11">(%), </span>
   <span class="font11">(.%). </span>
   <span class="font11">./journal.pone..tTable </span>
   <span class="font11">ANOVA </span>
   <span class="font11">Age </span>
   <span class="font11">Dis. </span>
   <span class="font11">Healthcare </span>
   <span class="font11">Immunology: </span>
   <span class="font11">Infectious </span>
   <span class="font11">Serum </span>
   <span class="font11">Statistical </span>
   <span class="font11">Therefore, </span>
   <span class="font11">Togaviruses: </span>
   <span class="font11">Virus </span>
   <span class="font11">age, </span>
   <span class="font11">ages </span>
   <span class="font11">antibodies. </span>
   <span class="font11">bold </span>
   <span class="font11">collab: </span>
   <span class="font11">confidence </span>
   <span class="font11">congenital </span>
   <span class="font11">considered </span>
   <span class="font11">control </span>
   <span class="font11">courier; </span>
   <span class="font11">coverage. </span>
   <span class="font11">decrease </span>
   <span class="font11">disease, </span>
   <span class="font11">em; </span>
   <span class="font11">entire </span>
   <span class="font11">epidemic </span>
   <span class="font11">epidemiological </span>
   <span class="font11">equal </span>
   <span class="font11">increased </span>
   <span class="font11">inhabitants </span>
   <span class="font11">low </span>
   <span class="font11">male </span>
   <span class="font11">natural </span>
   <span class="font11">northern </span>
   <span class="font11">periods. </span>
   <span class="font11">programme </span>
   <span class="font11">pt;} </span>
   <span class="font11">ranged </span>
   <span class="font11">recommended </span>
   <span class="font11">research </span>
   <span class="font11">result </span>
   <span class="font11">sample </span>
   <span class="font11">syndrome </span>
   <span class="font11">trend </span>
   <span class="font11">value </span>
   <span class="font11">youngest </span>
   <span class="font11">â€". </span>
  </p>
 </body>
</html>
